Agent Target Stage Phase NCI number Glembatumumab vedotin gpNMB Metastatic I NCT01997333 Panitumumab + chemotherapy EGFR Neoadjuvant II NCT02593175 Selumetinib MEK Neoadjuvant II NCT02685657 Veliparib + lapatinib PARP, EGFR/Her-2 Metastatic…
and Doris R. Brown1 (1) Department of Radiation Oncology, Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA Doris R. Brown Email: drbrown@wakehealth.edu KeywordsBreast cancerRadiotherapyRegional nodal irradiationPostmastectomy radiotherapyInternal mammary nodal irradiationNeoadjuvant…
Study Year published Study period Percentage increase in CPM of all patients over the study period Percentage increase in CPM of all mastectomy patients over the study period Data source…
© Springer International Publishing AG 2018Marissa Howard-McNatt (ed.)Changing Paradigms in the Management of Breast Cancer https://doi.org/10.1007/978-3-319-60336-0_4 4. Management of the Axilla in Breast Cancer Toan T. Nguyen1 and Judy C. Boughey1 (1) Department of Surgery, Mayo Clinic, 200…
Study Intervention Positive margin rate Re-excision rate Arm n % p-value % p-value Comice MRI 816 13%a n/s 16% 0.77 No MRI 807 15%a 19% Monet MRI 74 n/s n/s…
